Heterologous immunity to Epstein-Barr virus: dissecting the role of cross-reactive CD8 T cells in mediating disease outcome in children, young adults and the elderly

Project Information

EBV HORIZONS

Grant agreement ID: 219603

Closed project

Start date 1 May 2008

End date 30 April 2011

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 240 373,81

EU contribution € 240 373,81

Coordinated by

CARDIFF UNIVERSITY
United Kingdom